Does aspirin use reduce the risk of all cancers?

Question

Accepted Answer

Aspirin Use Does Not Reduce the Risk of All Cancers

Regular aspirin consumption has demonstrated a notable reduction in the risk of certain cancers, primarily those affecting the colon and gastrointestinal tract. However, this protective effect is not universal across all cancer types. Research indicates that while aspirin use may lower the overall risk of developing any form of cancer, it does not appear to offer a similar benefit for common cancers such as breast, lung, and prostate cancer.
Reduced Risk for Gastrointestinal Cancers

Studies have shown that individuals who regularly take aspirin, either standard or low-dose, at least twice weekly experienced a 3% lower risk of developing any type of cancer compared to those who did not. More specifically, aspirin use was linked to a 19% reduction in the risk of colorectal cancer and a 15% decrease in the risk of any gastrointestinal cancer. This benefit was observed after at least five years of continuous use, with dosages ranging from 0.5 to 1.5 standard tablets weekly or one low-dose tablet daily.
Potential Prevention of Gastrointestinal Tumors

The potential impact of regular aspirin use on preventing gastrointestinal tumors in the United States is substantial. Projections suggest that it could prevent close to 30,000 gastrointestinal tract tumors annually. Furthermore, it is estimated to prevent an additional 7,500 colorectal tumors among US adults over 50 who undergo endoscopic screening, and 9,800 among the nearly 30 million who do not. This suggests aspirin could serve as a complementary measure to established screening practices.
No Observed Benefit for Common Cancers

Despite the observed benefits for gastrointestinal cancers, the same protective effect was not found for other prevalent cancer types. When researchers specifically examined common cancers like breast, lung, and prostate cancer, there was no discernible reduction in risk associated with regular aspirin use. This finding underscores that the anti-cancer properties of aspirin appear to be site-specific, primarily targeting the digestive system.

Reading history

Hide →

This history is cleared when the page is closed.

Does aspirin use reduce the risk of all cancers?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends